Latest news
Sight loss 'brushed to one side' at work before counselling
Posted: Wednesday 31 August 2022
A new employment counselling group provided a nursery worker with the confidence to take control of her macular condition at work after initially describing her ‘put up and shut up’ attitude.
Find out more
New Best disease online support group launches
Posted: Wednesday 31 August 2022
People living with Best disease will be the latest to benefit from a new condition-specific support group launching later this month.
Find out more
Faricimab - all you need to know about the new treatment for wet AMD and DMO
Posted: Tuesday 30 August 2022
"There's a long way to go but I'm more optimistic. I was thinking of retiring a few years ago, now I'm so excited about the treatments we can offer patients I'll probably stay another few years."
Find out more
Cost of living crisis: what support is available if you are visually impaired?
Posted: Thursday 25 August 2022
Many people living with sight loss already face additional, unavoidable costs. So, when the country is facing a cost of living crisis, this undoubtedly has more of an impact on anyone living with a visual impairment.
Find out more
Help needed to test home-monitoring app
Posted: Friday 12 August 2022
A digital health company which has developed a new app to enable people with macular disease to monitor their vision from home is looking for volunteers.
Find out more
Thousands of patients with diabetes-related sight loss given access to new treatment
Posted: Thursday 11 August 2022
Thousands of patients with diabetic macular oedema (DMO) could benefit from a steroid treatment, which has previously only been available to those who have received cataract surgery.
Find out more
"It could be life-changing for so many people"
Posted: Wednesday 3 August 2022
A 75-year-old man involved in a clinical trial for a new implant for wet age-related macular degeneration (AMD) says it would be ‘magic’ if the trial is successful.
Find out more
Ophthalmologist to reveal more about new drug for two types of macular disease
Posted: Wednesday 3 August 2022
An ophthalmologist who has worked on the clinical trials for the latest drug approved to treat wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO) will reveal more about the treatment and how you can access it, as part of the Macular Society’s monthly webinar series.
Find out more
New National Clinical Director for Eye Care appointed
Posted: Monday 1 August 2022
A new role which could help transform eye care services for people living with macular disease and other sight conditions, has been appointed by NHS England.
Find out more
New treatment option approved for patients with diabetic macular oedema
Posted: Thursday 28 July 2022
Patients living with diabetes-related sight loss could be treated with a new drug, following a recommendation from The National Institute for Health and Care Excellence (NICE).
Find out more
Cheaper drugs for wet AMD becoming available on the NHS
Posted: Tuesday 19 July 2022
New forms of anti-VEGF drugs will soon be available to treat wet age-related macular degeneration (AMD) thanks to the production of biosimilars.
Find out more
Double donations for Amazon Prime Day
Posted: Thursday 7 July 2022
The Macular Society will benefit from double donations on eligible purchases made by Amazon Prime members later this month, helping us to raise vital funds for macular research.
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter